Cargando…
Relationship between MAN2B1 genotype/subcellular localization subgroups, antidrug antibody detection, and long‐term velmanase alfa treatment outcomes in patients with alpha‐mannosidosis
Alpha‐mannosidosis (AM), an autosomal recessive disorder caused by pathogenic biallelic variants in the MAN2B1 gene, leads to lysosomal alpha‐mannosidase deficiency and accumulation of mannose‐rich oligosaccharides. Velmanase alfa (VA), a recombinant human lysosomal alpha‐mannosidase, is the first e...
Autores principales: | Borgwardt, Line Gutte, Ceravolo, Ferdinando, Zardi, Giulia, Ballabeni, Andrea, Lund, Allan Meldgaard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981422/ https://www.ncbi.nlm.nih.gov/pubmed/36873087 http://dx.doi.org/10.1002/jmd2.12349 |
Ejemplares similares
-
Can velmanase alfa be the next widespread potential therapy for alpha-mannosidosis?
por: Abdul Ghani, Sundus, et al.
Publicado: (2023) -
Use of the Bruininks-Oseretsky test of motor proficiency (BOT-2) to assess efficacy of velmanase alfa as enzyme therapy for alpha-mannosidosis
por: Phillips, Dawn, et al.
Publicado: (2020) -
Comprehensive long-term efficacy and safety of recombinant human alpha-mannosidase (velmanase alfa) treatment in patients with alpha-mannosidosis
por: Lund, Allan M., et al.
Publicado: (2018) -
Early biochemical effects of velmanase alfa in a 7‐month‐old infant with alpha‐mannosidosis
por: Santoro, Lucia, et al.
Publicado: (2020) -
Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation
por: Borgwardt, Line, et al.
Publicado: (2015)